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The vigorous cytokine response of immune cells to Gram-negative bacteria is primarily mediated by a recognition
molecule, Toll-like receptor 4 (TLR4), which recognizes lipopolysaccharide (LPS) and initiates a series of intracellular
NF-jB–associated signaling events. Recently, bladder epithelial cells (BECs) were reported to express TLR4 and to
evoke a vigorous cytokine response upon exposure to LPS. We examined intracellular signaling events in human BECs
leading to the production of IL-6, a major urinary cytokine, following activation by Escherichia coli and isolated LPS. We
observed that in addition to the classical NF-jB–associated pathway, TLR4 triggers a distinct and more rapid signaling
response involving, sequentially, Ca
2þ, adenylyl cyclase 3–generated cAMP, and a transcriptional factor, cAMP
response element–binding protein. This capacity of BECs to mobilize secondary messengers and evoke a more rapid IL-
6 response might be critical in their role as first responders to microbial challenge in the urinary tract.
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Introduction
The innate immune system is the ﬁrst line of defense
against infection and is thought to primarily be mediated by
phagocytic immune cells such as macrophages and dendritic
cells. These cells recognize microorganisms via a limited
number of germline-encoded pattern recognition receptors
(PRRs) that recognize microbial components known as
pathogen-associated molecular patterns, which are essential
for the survival of the microorganism and, therefore, difﬁcult
for the microorganism to alter [1]. Several classes of PRRs,
including Toll-like receptors (TLRs) and cytoplasmic recep-
tors, recognize distinct microbial components and directly
activate immune cells, triggering intracellular signaling
cascades that rapidly induce the expression of a variety of
inﬂammatory cytokines that initiate a variety of overlapping
immune responses. One of the best known PRRs is TLR4,
which recognizes the major Gram-negative bacterial surface
component lipopolysaccharide (LPS) [1]. Studies on TLR4
signaling in monocytes, macrophages, and dendritic cells
have revealed that engagement of TLR4 by LPS triggers a
signaling cascade involving several intracytoplasmic and
nuclear transcriptional factors. TLR4 activation ﬁrst engages
a set of adaptor family members that link TLR4 to the serine/
threonine kinases. These kinases mediate phosphorylation
and ubiquitination of various substrates, eventually resulting
in the activation of the transcriptional factor NF-jB, which
regulates the expression of several immunomodulatory
cytokines [2].
The urinary tract is extremely intractable to infection by
most pathogens. This is attributable to a large extent on the
multifaceted innate immune defenses of the bladder and, in
particular, bladder epithelial cells (BECs). These cells selec-
tively exfoliate upon bacterial colonization and undergo re-
epithelialization as a mechanism to reduce bacterial load in
the bladder. They are also a major source of proinﬂammatory
cytokines and chemokines in the urinary tract following
bacterial infection [3,4]. These BEC-derived mediators are
responsible for the vigorous neutrophil response, which is
responsible for early clearance of infecting bacteria [5]. A
prominent mediator released by BECs is IL-6 and it is, by far,
the single most prominent cytokine detected in the urine of
infected patients [6]. IL-6 is known to mobilize and amplify
both local as well as systemic innate immune defenses against
infection [7]. The production of some of the earliest
indicators of inﬂammation in the body such as the acute
phase proteins has been directly related to production of this
cytokine [7].
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infecting the urinary tract, it is remarkable that uropatho-
genic Escherichia coli (UPEC) account for over 85% of urinary
tract infections in patients without underlying predisposing
factors [8]. The singular success of UPEC in the urinary tract
has been attributed to bacterial surface expression of
ﬁlamentous ﬁmbrial appendages, called type 1 ﬁmbriae [9].
These structures promote avid bacterial binding to uroplakin
1a molecules on the surface of BECs, triggering bacterial
invasion of these cells [10,11]. In their intracellular location,
UPEC avoid elimination by the ﬂushing actions of urine [12].
Recent studies have suggested additional traits on UPEC that
account for their success as uropathogens. These include
their capacity to block apoptosis and exfoliation of infected
BECs [13] as well as inhibit the ability of BECs to mount a
cytokine responses [14]. Although several genes on UPEC
have been implicated in inhibiting cytokine production, the
underlying mechanism remains elusive, a problem exacer-
bated, at least partly, by the fact that most of our current
understanding of TLR4 signaling is based almost exclusively
on cells of hematopoietic origin [1]. Here, we sought to better
deﬁne LPS/TLR4 signaling pathway in BECs. We were
especially interested in deﬁning the role, if any, of two
second messengers, Ca
2þ and cyclic adenosine monophos-
phate (cAMP), since these low molecular weight diffusible
molecules have been globally implicated in cellular signaling
events, including cytokine responses. We investigated the IL-6
responses of human BECs to E. coli and to isolated LPS. Our
studies demonstrated that the IL-6 response triggered by
TLR4 in BECs involves not only the classical NF-jB–
associated pathway, but also a distinct pathway involving
Ca
2þ, cAMP, and cAMP response element–binding protein
(CREB). Interestingly, the latter pathway resulted in a
signiﬁcant IL-6 response, which is evident at least 3 h before
the NF-jB–associated pathway.
Materials and Methods
Bacteria and BECs
A K-12 laboratory E. coli strain ORN103(pSH2) and a UPEC
type 1 ﬁmbriated and non-hemolytic strain CI5 were utilized
in this study [15–17]. Bacteria and the human BEC line 5637
(ATCC HTB-9) and primary BECs were cultured as described
previously [11,18]. Human airway epithelial cells (16-HBE)
were cultured in DMEM plus 4 mM glutamine and 10% FBS,
and the human monocytic cell line (Mono Mac 6) was
cultured as described previously [19].
IL-6 Measurements
IL-6 secretion was tested by using the human IL-6 ELISA
kit (R&D Systems, http://www.rndsystems.com) according to
the manufacturer’s protocol. Cell viability was not affected by
any of the pharmacological agents employed, as assessed by
trypan blue exclusion assays.
Ratiometric Imaging
Ratiometric Ca
2þ imaging was performed as described
previously [20]. The Fura-2 calcium imaging calibration kit
(Molecular Probes, http://probes.invitrogen.com) was used to
calibrate ﬂuorimetric analyses to quantify intracellular
calcium concentrations.
Measurement of Intracellular cAMP Levels
Intracellular concentrations of cAMP were determined
using a cAMP enzyme immunoassay kit (Sigma, http://www.
sigmaaldrich.com) according to the manufacturer’s instruc-
tions.
RNA Isolation and RT-PCR
Total cellular RNA was isolated using an RNeasy puriﬁca-
tion system (Qiagen, http://www.qiagen.com). Two micro-
grams of total RNA was reverse transcribed and ampliﬁed
with gene-speciﬁc primers using the RT-PCR System kit (Bio-
Rad, http://www.bio-rad.com). The primer sequences for the
genes and expected product sizes are summarized in Table
S1. We conﬁrmed that the adenylyl cyclase (AC) isotype-
speciﬁc primers were functional by undertaking reverse
transcription (RT)–PCR on total RNA from HEK cells (a
positive control cell, where all ACs except AC-4 and AC-8
were expressed) [21].
Creation of Knockdowns Using RNA Interference
Detailed methods and target sequences, including GenBank
accession numbers for the genes mentioned in this study, are
described in Text S1.
Western Blot Analysis
Detailed methods and materials are described in Text S1.
Detection of NF-jB Nuclear Translocation
Nuclear extraction kit (Chemicon, http://www.chemicon.
com) was used for performing a nuclear extraction, and the
active form of NF-jB contained in the nuclear extract was
detected using an NF-jB p65 Transcription Factor assay
system (Chemicon).
CREB Binding Assay
We employed the Noshift transcription factor assay system
(Novagen, http://www.emdbiosciences.com/html/NVG/home.
html) to assay binding of CREB to CRE oligonucleotides.
BECs were cultured and exposed for 1 h to E. coli
ORN103(pSH2), and nuclear extracts were collected following
the vendor’s recommendation (Novagen). To detect the
binding of CREB to the CRE site of the IL-6 promoter, CRE
oligonucleotides from IL-6 promoter region were synthesized
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Author Summary
In spite of frequent cross contamination by bacteria from the gut,
urinary tract infections are relatively infrequent. Although much of
the credit goes to cells lining the urinary tract, such as bladder cells,
how this is achieved remains unclear. Human bladder cells display,
on their surfaces, special molecules called Toll-like receptors, which
sense the presence of bacteria and trigger the cells to release a
variety of chemicals called cytokines. Cytokines contribute to the
recruitment of phagocytic cells from the blood to the site of
infection to clear bacteria. In this paper, we reveal that the Toll-like
receptor–initiated intracellular signals leading to the production of
cytokines by bladder cells involve the same pathway seen in other
cells, as well as an additional and more rapid signaling pathway.
Rapid production of cytokines by bladder cells will facilitate early
clearance of bacteria. Additionally, possession of multiple signaling
pathways by bladder cells for producing cytokines is advantageous
because bacteria that infect the urinary tract have the capability to
suppress certain signaling events that lead to cytokine production
by bladder cells.and end-labeled by biotinylation. The CRE oligonucleotide
sequences utilized were the same as those used previously [22].
Results
IL-6 Response of BECs to Type 1 Fimbriated E. coli Is
Largely Elicited by LPS and Involves TLR4
Although there are several data implicating type 1 ﬁmbriae
and its adhesive subunit, FimH, as the determinant largely
responsible on UPEC for triggering endocytic responses from
BECs [10,11], a recent study has reported LPS as the primary
determinant on UPEC responsible for evoking the cytokine
response from BECs [23]. We initiated our studies by
examining the role of LPS in mediating the IL-6 response of
BECs following exposure to E. coli. This was undertaken by
comparing the IL-6 response of the human BEC line 5637 to E.
coli in the presence and absence of polymyxin B (PMB), which
binds to the lipid A portion of LPS and blocks its recognition
by host cells [23]. The E. coli strain we selected for our studies
was a well-characterized laboratory strain of E. coli
ORN103(pSH2) expressing recombinant type 1 ﬁmbriae,
including the adhesive subunit, FimH. We employed this
laboratory strain rather than a UPEC strain because UPEC
strains express multiple genes capable of suppressing cytokine
responses in BECs [14]. We observed a strong IL-6 response
from BECs following exposure to the laboratory E. coli that was
signiﬁcantly reduced following pretreatment of the bacteria
with PMB (Figure 1A). For comparative purposes, shown in
Figure 1A is the PMB-mediated inhibition of the IL-6
responses of BECs to soluble E. coli LPS. Due to the possibility
of lipoprotein contamination of LPS prepared by trichloro-
acetic acid (TCA) or phenol-chloroform-petroleum ether
(PCP) extraction, LPS ultra puriﬁed by ion exchange
chromatography and veriﬁed to contain ,1% protein was
used in this study (Sigma; E. coli 055:B5 LPS). To conﬁrm that
the LPS on E. coli was the primary determinant responsible for
activating BECs, we sought to show that the activation of BECs
involved TLR4, the signaling receptor for LPS. Using RNA
interference (RNAi) techniques, we generated BECs where
expression of TLR4 was appreciably knocked down. Densito-
metric quantiﬁcation of message levels in the knockdown (KD)
BECs revealed that the expression of TLR4 was reduced by
49% (Figure 1B). Shown in Figure 1C is the IL-6 response of
control (transfected with control vector) BECs and of the KD
BECs to E. coli and LPS. Compared to control BECs, signiﬁcant
reduction in the IL-6 response to both E. coli and LPS was
observed with the KD cells (Figure 1C). For the most part, the
reduction in the IL-6 response paralleled the degree of KD of
TLR4 in the BECs (Figure 1B–1C). Taken together, these data
conﬁrm that LPS is the primary determinant on E. coli
responsible for triggering the IL-6 response, and the intra-
cellular signaling triggered by LPS involves TLR4 on BECs.
IL-6 Response of BECs to E. coli Is Preceded by an Increase
in Intracellular Ca
2þ
Since intracellular Ca
2þ ([Ca
2þ]i) has been implicated in
important cellular processes, including IL-6 secretion [20,24],
we examined the involvement, if any, of this second
messenger in the IL-6 response of BECs to E. coli.W e
investigated whether exposure of BECs to E. coli induced an
increase in [Ca
2þ]i by performing ratiometric imaging on
Fura-2/AM-loaded 5637 BECs. A unique pattern of Ca
2þ
inﬂux into exposed BECs to E. coli was observed (Figure 2A).
BEC [Ca
2þ]i was constant before bacterial exposure and
increased rapidly, within 1 min, after E. coli exposure,
returning to baseline levels within 5 min (Figure 2A). To
determine whether the E. coli–induced increase of [Ca
2þ]i was
essential for the BEC IL-6 response to bacterial exposure, we
examined IL-6 secretion by BECs following bacterial expo-
sure with or without pretreatment with NiCl2, a general Ca
2þ
channel inhibitor [25], or BAPTA-AM, a [Ca
2þ]i chelator [26]
(Figure 2B). Whereas BEC IL-6 secretion was readily induced
after exposure to E. coli, pretreatment of BECs with NiCl2 or
BAPTA-AM before bacterial exposure completely abolished
IL-6 secretion by exposed BECs to E. coli. In addition, a
general inducer of calcium inﬂux, ionophore A23187, was
Figure 1. IL-6 Response of BECs to Type 1 Fimbriated E. coli Is Largely
Elicited by LPS and Involves TLR4
(A) IL-6 secretion by BECs in response to E. coli (100 multiplicity of
infection) or purified LPS (100 lg/ml). When specified, E. coli and purified
LPS were pretreated with 1 lg/ml PMB for 30 min. **, p , 0.001 relative
to values of untreated (UT) BECs; *, p , 0.03 relative to E. coli or LPS-
treated BECs.
(B) RT-PCR of control-transfected BECs (Ctrl) and TLR4 KD BECs.
Glyseraldehyde-3-phosphate dehydrogenase (GAPDH) was employed
as a loading control.
(C) IL-6 secretion of control-transfected BECs (Ctrl) and TLR4 KD BECs
after E. coli and LPS stimulation. **, p , 0.05 relative to UT control; *, p ,
0.05 relative to E. coli-treated control or LPS control.
doi:10.1371/journal.ppat.0030060.g001
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E. coli, demonstrating the importance of [Ca
2þ]i increases in
initiating this response.
We also investigated whether puriﬁed E. coli LPS was
capable of inducing an increase in [Ca
2þ]i in BECs. LPS was
seen to induce a similar, but delayed, increase in [Ca
2þ]i
compared to that caused by E. coli (Figure 2A and 2C). The
LPS-induced [Ca
2þ]i peak occurred ;5 min after the addition
of 100 lg/ml LPS. Disrupting the LPS-induced [Ca
2þ]i increase
with NiCl2 or BAPTA-AM pretreatment before LPS exposure
greatly reduced IL-6 production by BECs (Figure 2D).
Pretreatment of LPS with PMB almost completely abrogated
the [Ca
2þ]i response of BEC (Figure 2E). Taken together, these
observations provide strong evidence indicating that the IL-6
response of BECs to E. coli involves a sharp increase in [Ca
2þ]i
levels. Although LPS appears to be the primary bacterial
component responsible for elevation of [Ca
2þ]i, bacteria-
associated LPS evoked a faster [Ca
2þ]i response in BECs
compared to that of soluble LPS.
IL-6 Response of BECs to E. coli Is Associated with a
Significant Increase in Intracellular cAMP Levels
Intracellular cAMP is an important second messenger in
several signaling pathways, including IL-6 response [27–29].
Exposing BECs to E. coli for 1 h demonstrated a 2.7-fold
increase in intracellular cAMP, which was blocked by
inhibiting AC activity with the compound MDL-12,330A
(MDL) (Figure 3A). The increase in intracellular cAMP
following bacterial exposure was dependent on both bac-
teria-associated LPS and an increase in [Ca
2þ]i as shown,
respectively, by pretreating the bacteria with PMB or
pretreating the BECs with NiCl2 (Figure 3B). This E. coli–
induced [Ca
2þ]i-dependent cAMP production was found to be
an important step in the cytokine response of BECs to
bacterial exposure, since inhibition of ACs with MDL reduced
BEC IL-6 expression by ;75% (Figure 3C). In addition, a
membrane-permeable cAMP analog, dibutyryl cAMP, in-
duced a greater than 3-fold increase in BEC IL-6 production
in the absence of bacterial exposure, demonstrating the
importance of intracellular cAMP in inducing BEC IL-6
production. However, a membrane-permeable cAMP analog
(8-CPT-cAMP) that does not activate the classical cAMP-
target protein, protein kinase A (PKA), but only activates the
recently discovered cAMP-target protein Epac (exchange
protein activated by cAMP) [30], did not induce the
production of BEC IL-6, indicating that PKA is involved in
the downstream induction of IL-6 production by exposed
BECs to E. coli (Figure 3C). Forskolin activates ACs, the
enzymes that produce intracellular cAMP, by a direct
mechanism [31], which should bypass the need for an increase
Figure 2. IL-6 Response of BECs to E. coli Is Preceded by an Increase in [Ca
2þ]i
(A) [Ca
2þ]i tracing of BECs before and after E. coli exposure. E. coli was added at time 0.
(B) BEC IL-6 responses after E. coli exposure in the absence or presence of NiCl2 (2 mM) or BAPTA-AM (5 lM), or after calcium ionophore A23187 (1 lM)
treatment without bacterial exposure. *, p , 0.001 relative to untreated (UT) BECs; **, p , 0.001 relative to E. coli (EC)–treated BECs.
(C–E) BEC [Ca
2þ]i tracing before and after purified LPS treatment (C) or PMB pretreated LPS treatment (E). (D) BEC IL-6 responses following exposure to
LPS in the absence or presence of NiCl2 or BAPTA-AM. *, p , 0.001 relative to UT BECs; **, p , 0.01 relative to LPS-treated BECs.
doi:10.1371/journal.ppat.0030060.g002
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2þ]i that is observed with E. coli–induced intracellular
cAMP production. As shown in Figure 3D, direct activation of
AC by forskolin led to a dramatic production of IL-6 that was
not inhibited by NiCl2, indicating that the increase in [Ca
2þ]i
that occurred after E. coli exposure preceded the production
of intracellular cAMP. Neither NiCl2 nor PMB treatment
affected forskolin-induced IL-6 production, demonstrating
that these agents did not have a detrimental effect on protein
synthesis in general (Figure 3D). Thus, the IL-6 response to E.
coli evoked by BECs involves another secondary messenger,
cAMP, which acts downstream of the Ca
2þ response.
AC-3 Is Responsible for Mediating E. coli–Induced cAMP in
BECs
Because there are currently ten known isoforms of
mammalian ACs [32] it was of interest to determine which
AC was responsible for the E. coli–induced increase of
intracellular cAMP in BECs. First, we determined which AC
isoforms were actually expressed in BECs. RT-PCR was
performed on total cellular RNA, using primers speciﬁc for
each known AC isoform and only mRNA for AC isoforms AC-
3, AC-4, AC-6, and AC-7 was detectable in BECs (Figure 4A).
We conﬁrmed that the other AC isotype-speciﬁc primers used
were functional by undertaking RT-PCR on total RNA from
human embryonic kidney (HEK) cells, positive control cells,
where all ACs except AC-4 and AC-8 were expressed [21]
(unpublished data). RNAi was utilized to minimize the
expression of each AC, which was veriﬁed by AC isotype-
speciﬁc RT-PCR (Figure 4B). Following E. coli exposure,
intracellular cAMP, as well as IL-6 secretion, rose signiﬁcantly
in all of the KDs, except for the KD of AC-3, indicating that
AC-3 is the BEC AC isoform linked to the IL-6 response
following E. coli exposure (Figure 4C and 4D). It is noteworthy
that of the four AC isoforms expressed by BECs, only AC-3 is
known to be activated by increases in [Ca
2þ]i [33,34]. The KD
of AC-3 also abrogated the production of intracellular cAMP
(Figure 4E) and expression of IL-6 (Figure 4F) following
exposure of BECs to puriﬁed LPS. Interestingly, in the AC-3
KD BECs, forskolin-induced IL-6 expression was largely
unaffected (Figure 4F). The appreciable IL-6 response to
forskolin suggested that a general increase in intracellular
cAMP was sufﬁcient to signal IL-6 secretion in BECs. The
absence of any reduction in the IL-6 response to forskolin in
AC-3 KD BECs is attributable to the presence of other
isoforms of ACs in these cells, which were directly activated
by forskolin. Remarkably, when AC-3–speciﬁc Western
blotting was performed on BECs before and after bacterial
exposure or exposure to puriﬁed LPS, no discernible increase
in the expression of AC-3 protein was observed, indicating
that an increase in activity, rather than expression, of AC-3
occurred following infection (Figure 4G and 4H). Finally,
when we examined for increase in [Ca
2þ]i in the AC-3 KD
BECs following exposure to E. coli, we found that it was
comparable to that seen in wild-type (WT) BECs (Figure 4I),
which is consistent with the idea that the rise in [Ca
2þ]i
preceded any rise in intracellular cAMP.
cAMP-Mediated Phosphorylation of the CREB
Next, we sought to connect the Ca
2þ- and cAMP-dependent
signaling events described in this study to the classical NF-
Figure 3. IL-6 Response of BECs to E. coli Is Associated with a Significant Increase in Intracellular cAMP Levels
(A and B) BEC cAMP production before and after E. coli exposure. When specified, BECs were pretreated with MDL-12,330A (MDL) (0.4 mM) or NiCl2 for
30 min, or E. coli was pretreated with PMB for 30 min. *p , 0.03 relative to untreated (UT) BECs; **p , 0.03 relative to E. coli (EC)–treated BECs.
(C) IL-6 secretion by BECs was measured 6 h after exposure to E. coli, in the absence (EC) or presence of MDL-12,330A (EC, MDL), or after 6 h of treatment
with 1 mM dibutyryl cAMP (dbcAMP), or 1 mM 8-(4-chloro-phenylthio)-29-O-methyladenosine-39-59-cyclic monophosphate (8-CPT-cAMP) without
bacterial exposure. *, p , 0.01 relative to UT; **, p , 0.02 relative to EC.
(D) IL-6 secretion by BECs incubated for 6 h in the absence (UT) or presence of the AC-activator forskolin (Fors) (50 lM) with or without NiCl2 or PMB, or
incubated with NiCl2 or PMB in the absence of forskolin. *, p , 0.01 relative to UT BECs.
doi:10.1371/journal.ppat.0030060.g003
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cAMP to the classical pathway, we examined its effects on the
translocation of the transcriptional factor NF-jB from the
cytoplasm to the nucleus following bacterial exposure.
Remarkably, when we examined control-transfected BECs
and AC-3 KD BECs 1 h following exposure to E. coli (which
corresponds to the time we observed signiﬁcant secondary
messenger responses) for nuclear translocation, we found
little or no translocation of NF-jB in either cell type (Figure
5A). However, when we increased the incubation time to 2 h
following exposure to E. coli, we detected a marked increase in
translocation of NF-jB in control-transfected BECs, and an
identical increase was also seen in AC-3 KD BECs (Figure 5B).
This ﬁnding revealed that (i) the cAMP responses in BECs
preceded the nuclear translocation of NF-jB by signiﬁcant
amounts of time, and (ii) these cAMP responses did not
appear to impact the NF-jB–associated signaling pathway.
These observations raised the intriguing possibility that
secondary messengers such as cAMP may be acting via an
independent pathway. To see whether the regulatory effect of
cAMP on the IL-6 response was at the transcriptional level,
we compared IL-6 mRNA levels in WT BECs, control-
transfected BECs, and AC-3 KD BECs before and 1 h after
exposure to E. coli. We observed a marked increase in IL-6
mRNA in WT BECs and control-transfected BECs but not in
AC-3 KD BECs (Figure 5C), indicating that the AC-3–
mediated elevation in intracellular cAMP was regulating the
IL-6 response at the transcriptional level. It is pertinent to
also note the time frame of when these assays were under-
taken. Here, mRNA for IL-6 was detected in control-trans-
fected BECs as early as 1 h after exposure to E. coli (Figure 5C).
Considering that nuclear translocation of NF-jB was detect-
able only after 2 h (Figure 5B), this cAMP-regulated pathway
appears to be activated sooner than the classical pathway.
Figure 4. AC-3 Is responsible for Mediating E. coli–Induced cAMP Production in BECs
(A) RT-PCR of BECs using primers specific for the ten known mammalian AC isoforms. Only AC-3, AC-4, AC-6, and AC-7 mRNA was expressed. GAPDH-
specific RT-PCR (lane G) was used as a loading control. M, marker; sAC, soluble AC.
(B) RT-PCR of control-transfected BECs (Ctrl) and AC-3, AC-4, AC-6, or AC-7 KD BECs. GAPDH-specific RT-PCR was used as a loading control.
(C and D) Intracellular cAMP production (C) and IL-6 secretion (D) by non-transfected BECs (NT), control-transfected BECs (Control), or AC-3, AC-4, AC-6,
or AC-7 KD BECs left untreated (UT) or treated with E. coli (EC). *, p , 0.005 and **, p , 0.02 relative to respective UT values.
(E and F) Intracellular cAMP production (E) and IL-6 secretion (F) by non-transfected BECs (NT), control-transfected BECs (Control), or AC-3 KD BECs were
measured in the absence (UT) or presence of E. coli LPS, or presence of forskolin (Fors) without LPS. *, p , 0.003 relative to respective UT values.
(G) BEC AC-3–specific Western blot before (UT) and after (EC) E. coli exposure for 1 h, or exposure to E. coli LPS for 6 h. An actin-specific Western blot was
used as a loading control.
(H) Densitometric analysis of AC-3–specific Western blots, using ImageJ software.
(I) [Ca
2þ]i tracing in AC-3 KD BECs before and after E. coli exposure. E. coli was added at time 0.
doi:10.1371/journal.ppat.0030060.g004
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mRNA 6 h after exposure to E. coli, we detected similar
amounts of message in AC-3 KD BECs and control-trans-
fected BECs (Figure 5D), indicating that the classical NF-jB–
mediated pathway was still functional in AC-3 KD BECs.
Thus, the IL-6 response in BECs appears to originate from
two distinct pathways: the NF-jB–associated pathway and a
separate but speedier pathway involving Ca
2þand cAMP. One
mechanism through which cAMP may directly affect tran-
scription of IL-6 is by promoting phosphorylation of CREB,
which binds to CRE in the IL-6 promoter region [35]. An
increase in intracellular cAMP levels activates PKA, whose
Figure 5. cAMP-Mediated Phosphorylation of CREB and Binding of CREB to CRE Oligonucleotides
(A and B) NF-jB nuclear translocation in control-transfected BECs and AC-3 KD BECs before and after E. coli (EC) exposure for 1 h (A) or 2 h (B). UT,
untreated.
(C and D) IL-6 message levels in non-transfected (NT), control-transfected (Ctrl), and AC-3 KD BECs before and after E. coli exposure for 1 h (C) or 6 h (D)
as measured by RT-PCR.
(E) Western blot of CREB phosphorylation levels (p-CREB) in UT BECs, and forskolin (Fors)– or calcium ionophore A23187 (A23187)–treated BECs. The
treatment was for 1 h.
(F) Western blot showing CREB phosphorylation of NT, Ctrl, and AC-3 KD BECs before and after 1 h E. coli exposure.
(G) CREB binding to CRE site of the IL-6 promoter. Nuclear extracts of BECs exposed for 1 h to E. coli ORN103(pSH2) were incubated with biotinylated WT
CRE oligonucleotides in the absence (Biotinylated WT CRE) or presence of specific (Biotinylated WT CREþWT CRE) or non-specific (Biotinylated WT CRE
þ MT CRE) oligonucleotide competitors. ***, p , 0.0001.
(H) Expression analysis of mRNA levels of various genes with CRE sites in their promoter. WT and AC-3 KD BECs were incubated for 1 h with E. coli
ORN103(pSH2), and then total RNA was collected from untreated (UI) and bacteria-treated BECs (EC) and subjected to RT-PCR. GAPDH was used as a
loading control.
doi:10.1371/journal.ppat.0030060.g005
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CREB [36]. Upon phosphorylation, CREB promotes the
recruitment of various transcriptional co-activators that
promote transcription of target genes with consensus sites
for CREB, such as IL-6 [37,38]. When we examined for CREB
phosphorylation in BECs exposed to forskolin and calcium
ionophore A23187, two potent elevators of intracellular
cAMP, we observed a marked increase in CREB phosphor-
ylation on the Western blots (Figure 5E) consistent with the
idea that CREB phosphorylation occurred following elevation
of intracellular cAMP levels. To see if bacterial exposure also
triggered phosphorylation of CREB, CREB protein from
extracts of BECs before and after exposure to E. coli was
probed for phosphorylation. Following E. coli exposure, we
found an appreciable increase in phosphorylation of CREB in
non-transfected BECs and control-transfected BECs, but not
in AC-3 KD BECs (Figure 5F). To extend these ﬁndings, we
investigated the binding of CREB to the CRE sites on the IL-6
promoter region. Nuclear extracts of BECs were obtained
after 1 h incubation with E. coli ORN103(pSH2) and then
incubated with the biotinylated oligonucleotides correspond-
ing to CRE on the IL-6 promoter. Binding of CREB to CRE
was assessed by a colorimetric assay. We found that CREB
bound to CRE oligonucleotides but not to a scrambled
oligonucleotide sequence of identical length (Figure 5G).
Thus, cAMP appears to be modulating IL-6 responses through
the binding of the phosphorylated transcriptional factor
CREB to the CRE site on the IL-6 promoter region.
Since there are other inﬂammatory mediators such as IL-
1a,I L - 1 b, and IL-8 with consensus CRE sites in their
promoter region that have known to be activated during
urinary tract infection [14,39,40], we examined whether
production of any of these mediators was modulated by the
cAMP/CREB pathway following exposure to E. coli.W e
compared message levels for IL-1a, IL-1b, and IL-8 in WT
and AC-3 KD BECs after 1 h exposure to E. coli
ORN103(pSH2). We found that mRNA levels for IL-8 but
not IL-1a or IL-1b appeared to be regulated by the TLR4/
cAMP/CREB pathway. Thus, in addition to IL-6, production
of IL-8 by BECs appears to be under the regulation of the
novel signaling pathway.
The IL-6 Response to E. coli of BECs Is the Product of Two
Separate Signaling Pathways
Based on the evaluation of transcriptional messages, the IL-
6 response of BECs is mediated by two separate signaling
pathways with different expression kinetics. To verify this
observation, we compared the kinetics of IL-6 secretion in
WT and AC-3 KD BECs following exposure to E. coli. We
found that whereas appreciable IL-6 secretion (arbitrarily
deﬁned as 4-fold over unstimulated controls) was observed as
early as 6 h in WT BECs, a comparable amount of IL-6 was
only produced in AC-3 KD BECs after about 9 h (Figure 6A).
By 12 h, however, the amounts of IL-6 secretion were not
signiﬁcantly different between both cell types, suggesting that
the IL-6 responses of AC-3 KD BECs eventually caught up to
that of the WT BECs (Figure 6A). A similar proﬁle was
obtained when we substituted the laboratory E. coli strain with
a UPEC strain, CI5 (Figure 6B). To assess the relative
contribution of the cAMP-mediated pathway to the IL-6
response of BECs, we examined E. coli–elicited IL-6 responses
of WT BECs after selective inhibition of the NF-jB pathway
with pyrrolidine dithiocarbamate [41]. This agent has been
reported not to inhibit CREB activity [42]. We found that
although the early kinetics of the IL-6 responses were not
signiﬁcantly different from untreated WT BECs, the amounts
of IL-6 secreted, especially by the 12 h period of incubation,
were signiﬁcantly reduced. Thus, while the cAMP/CREB–
Figure 6. The IL-6 Response to E. coli of BECs Is the Product of Two Separate Signaling Pathways
(A) IL-6 secretion response to E. coli ORN103(pSH2) by WT and AC-3 KD BECs in the absence or presence of pyrrolidine dithiocarbamate (PDTC).
(B) IL-6 secretion response to UPEC CI5 by WT and AC-3 KD BECs.
(C and D) IL-6 secretion responses by Mono Mac 6 cell line (C) and 16-HBE cell line (D). Cells were treated for 12 h with E. coli ORN103(pSH2) in the
absence (EC) or presence of NiCl2 or PKA inhibitor (PKI). *, p , 0.03 relative to untreated (UT) value. Identical results were obtained after 6 h of treatment
with E. coli ORN103(pSH2).
(E) Increased CREB phosphorylation in BECs in response to TLR2 and TLR3 ligands. Western blotting for phospho-CREB and total-CREB in UT BECs or
BECs treated with either a TLR2 ligand (lipoteichoic acid) or a TLR3 ligand (polyinosine-polycytidylic acid).
doi:10.1371/journal.ppat.0030060.g006
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generated by this pathway were signiﬁcantly less than that
produced by the classical NF-jB–associated pathway.
Additionally, we examined whether the IL-6 responses to E.
coli mediated by other human cells involved the two second
messengers, Ca
2þ and cAMP. Monolayers of the human
monocytic cell line Mono Mac 6, and the human bronchial
epithelial cell line 16-HBE, were exposed to E. coli
ORN103(pSH2) as before in the presence of inhibitors of
either Ca
2þ response or cAMP response, and IL-6 secretion
was measured. We found that whereas both cell lines evoked
appreciable IL-6 responses to E. coli, neither one of these
responses were reduced by inhibitors of calcium (NiCl2)o r
cAMP (PKA inhibitor) signaling (Figure 6C and 6D). Thus, the
two secondary messengers, Ca
2þ and cAMP, appear to be
important mediators of the IL-6 responses in BECs but not in
other cell types.
Since BECs express other TLRs such as TLR2 and TLR3
[23,43], it was of interest to investigate whether known ligands
for TLR2 and TLR3 also triggered the cAMP/CREB pathway.
We assessed the phosphorylation levels of CREB before and 6
h after exposure to lipoteichoic acid (TLR2 ligand) or
polyinosine-polycytidylic acid (TLR3 ligand) and found that
both TLR ligands induced signiﬁcant phosphorylation of
CREB (Figure 6E). Thus, the CREB pathway appears to be
activated by TLRs other than TLR4.
Involvement of [Ca
2þ]i and cAMP in the IL-6 Response of
Primary Human BECs to UPEC
Since the secondary messenger/CREB pathway was detect-
able only in immortalized human BECs, it was important to
validate our observation of the existence of a cAMP/CREB
pathway in primary human BECs. Therefore, we investigated
whether freshly isolated and cultured human BECs would
secrete IL-6 through a Ca
2þ- and cAMP-dependent mecha-
nism when exposed to UPEC strain CI5 [16]. We cultured
primary bladder cells obtained from fresh bladder biopsies as
described previously [44]. These cells exhibited characteristics
of primary BECs, including expression of uroplakin 1a, a
marker of the asymmetrical unit membrane, the junctional
complex protein ZO1, as well as cytokeratin, all of which are
hallmarks of terminal differentiation in bladder umbrella
cells (unpublished data). We observed that, after the
stimulation with UPEC strain CI5, primary BECs exhibited
elevation in [Ca
2þ]i (Figure 7A). The intensity of the response
was lower than that observed with the laboratory strain of E.
coli (unpublished data). This is consistent with the fact that
UPEC express multiple virulence factors, some of which
exhibit disparate effects on [Ca
2þ]i levels [20]. As demon-
strated previously with 5637 BECs, this response was
signiﬁcantly abrogated following pretreatment with the
general Ca
2þ channel blocker, NiCl2 (Figure 7B). Signiﬁcant
elevation in intracellular cAMP levels and IL-6 secretion was
observed in primary BECs following exposure to UPEC
(Figure 7C and 7D). Both the increase in intracellular cAMP
levels and IL-6 secretion were inhibitable by NiCl2, once
again conﬁrming the importance of [Ca
2þ]i to the BEC IL-6
response (Figure 7C and 7D). Also shown in Figure 7D is the
IL-6 response of these primary cells to the laboratory E. coli
strain ORN103. Notice that it is markedly higher than the
response to the UPEC strain. Taken together, these ﬁndings
Figure 7. The IL-6 Response of Primary Human BECs to UPEC Is Linked to [Ca
2þ]i and cAMP Increase
(A) [Ca
2þ]i tracing before and after exposure of primary human BECs to UPEC strain CI5.
(B) [Ca
2þ]i tracing of the primary human BECs pretreated with NiCl2 for 30 min. UPEC was added at time 0.
(C and D) Intracellular cAMP production (C), or IL-6 secretion (D) by the primary human BECs left untreated (UT) or treated with E. coli CI5 (UPEC) in the
absence or presence of NiCl2 (UPEC, NiCl2), or treated with E. coli ORN103 (EC). *, p , 0.03 relative to UT value. **, p , 0.03 relative to UPEC (CI5)–treated
value.
doi:10.1371/journal.ppat.0030060.g007
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primary BECs to UPEC is dampened, it involves a Ca
2þ- and
cAMP-dependent mechanism.
Discussion
The bladder and the upper urinary tract are typically
sterile, which is attributable, at least in part, to the highly
efﬁcient immune system monitoring these sites. One of the
principal effectors of immune surveillance is the epithelial
cell lining the urinary tract [3,45]. In addition to serving as a
barrier against urine, BECs function as ﬁrst responders,
mobilizing multiple innate immune responses against micro-
organisms. Mediating microbial recognition on the surfaces
of epithelial cells are PRRs, which recognize speciﬁc micro-
bial products and activate intracellular signaling events
leading to secretion of various inﬂammatory and immunor-
egulatory cytokines [43]. That epithelial cells possess PRRs
such as TLR4 and contribute to immune surveillance has only
recently been recognized [23,46]. For a long time it was
assumed that PRRs were exclusively found on immune cells of
hematopoietic origin and, therefore, most of our current
information regarding PRR-mediated signal transduction is
largely based on these cells [1,47]. Although there is no
conclusive data suggesting cell-speciﬁc TLR4 signaling, there
have been suggestions that LPSs evoke intracellular signaling
reactions in Kupffer cells [48] and tracheal epithelial cells [49]
that are absent in polymorphonuclear leukocytes [50]. Here,
we report the existence of a distinct TLR4-mediated signaling
pathway leading to IL-6 secretion that is present in BECs but
absent in other human cell types.
This novel signaling pathway detected in BECs is independ-
ent of the classical pathway involving the transcriptional
element NF-jB and contains two well-known secondary
messengers, Ca
2þ and cAMP, which mobilize a different
transcriptional element, CREB. The existence of this pathway
only became evident to us because of our focus on second
messengers in TLR signaling and because our assays for IL-6
production wereundertaken at earlier incubation periods than
the more traditional 24–48 h incubation time points [7]. At the
laterincubationperiods,thecontributionofthisnovelpathway
to the IL-6 response is superseded by the traditional NF-jB–
mediated pathway. Evidence for the involvement of [Ca
2þ]i in
the early BEC IL-6 response comes from the ﬁnding that a ﬂux
in [Ca
2þ]i was observed within a minute of exposure to E. coli,
and inhibiting this ﬂux with Ca
2þ channel inhibitors or [Ca
2þ]i
chelators inhibited the IL-6 response (Figure 2B). Since a
general inducer of calcium inﬂux such as ionophore A23187
was able to induce IL-6 production from BECs even in the
absence of E.coli,increase in[Ca
2þ]i appears sufﬁcient to trigger
the IL-6 response from BECs (Figure 2B). Evidence for the role
of cAMP in the IL-6 response comes from the ﬁnding that the
IL-6 response to E. coli was closely associated with a 3-fold
increaseinintracellularlevelsofcAMP(Figure 3A).In addition,
inhibition of cAMP-generating ACs signiﬁcantly reduced the
IL-6 response of BECs to E. coli (Figure 3C). As with the [Ca
2þ]i
ﬂux, merely enhancing intracellular levels of cAMP with a
membrane-permeable cAMP analog induced signiﬁcant IL-6
release from BECs even in the absence of E. coli (Figure 3C).
Thus, the two secondary messengers are sufﬁcient, as well as
necessary, for the early IL-6 secretion in BECs.
That Ca
2þ response preceded the cAMP production
following bacterial stimulation was deduced from the ﬁndings
that (i) the earliest detectable increase in intracellular cAMP
levels was observed 15 min following exposure to E. coli
(unpublished data), whereas Ca
2þ responses could be seen
within a minute of bacterial exposure (Figure 2A), and (ii) the
Ca
2þ ﬂux following exposure to E. coli remained largely
unaffected in AC-3 KD BECs, while the cAMP response was
abrogated (Figure 4I). Since enhancement of intracellular
cAMP speciﬁcally required an increase in [Ca
2þ]i,w e
suspected that a Ca
2þ-inducible form of AC was responsible.
BECs were found to express mRNA for AC-3, AC-4, AC-6, and
AC-7, but only RNAi KD of AC-3, a Ca
2þ-inducible AC
isoform, inhibited E. coli–induced intracellular cAMP pro-
duction and subsequent IL-6 expression.
To identify where in the signaling cascade cAMP was
exerting its effects, we compared IL-6 message levels in
control and AC-3 KD BECs. The absence of IL-6 message in
AC-3 KD BECs after 1 h of exposure to bacteria suggested
that cAMP was regulating IL-6 production at the transcrip-
tional level rather than at the levels of translation or cytokine
secretion. Since translocation of NF-jB into the nucleus of
BECs following exposure to E. coli was largely unaffected in
the AC-3 KD BECs (Figure 5B), cAMP may not be exerting its
effect through altering NF-jB. Interestingly, one way that
cAMP can directly promote expression of certain genes is to
activate PKA, which translocates to the nucleus, where it
phophorylates the transcriptional factor CREB [36]. Upon
phosphorylation, CREB is believed to promote transcription
of a number of genes, including IL-6, IL-8, IL-1a, and IL-1b,
which possess consensus CRE sites on their promoter region
[36,37,51–53]. Interestingly, in BECs, only IL-6 and IL-8
appear to be regulated by the cAMP/CREB pathway (Figure 5).
Figure 8. Proposed Model for TLR4 Signaling in BECs
The proposed rapidly induced second messenger– and CREB-mediated
pathway (dark line) as well as the classical NF-jB (grey line) are shown.
Both pathways are triggered by TLR4. P, phosphorylation; R and C,
regulatory and catalytic subunits of PKA.
doi:10.1371/journal.ppat.0030060.g008
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evident from CREB phosphorylation in control BECs follow-
ing exposure to E. coli but not in AC-3 KD BECs. Thus, taken
together, our cumulative data reveal the existence of a
distinct TLR4-activated signaling pathway in BECs involving
Ca
2þ, cAMP, and phosphorylated CREB. A diagrammatic
representation of the proposed TLR4-initiated Ca
2þ-, cAMP-
and CREB-dependent pathway, as well as the NF-jB pathway
in BECs, is shown in Figure 8. Although in the ﬁgure we have
indicated that the cAMP/CREB pathway in BECs is activated
by TLR4, our data also suggest that TLR2 and TLR3
activation may also trigger this pathway (Figure 6E).
Our analysis of the kinetics of IL-6 secretion in WT and AC-
3 KD BECs has revealed that this novel second messenger/
CREB-mediated pathway is mediating a faster IL-6 response
than the classical NF-jB–mediated pathway. Following ex-
posure of BECs to E. coli ORN103(pSH2), marked phosphor-
ylation of CREB was observed at least 1 h before nuclear
translocation of NF-jB was evident. Indeed, the earliest
evidence of nuclear translocation of NF-jB in BECs following
exposure to E. coli was at 2 h (Figure 5B). Another piece of
evidence implicating the second messenger/CREB pathway in
a rapid and distinct IL-6 response was the observation that a
message for IL-6 was detectable in control BECs 1 h following
exposure to E. coli, whereas no message for IL-6 was seen in
AC-3 KD BECs. However, by 6 h after the classical NF-jB
signaling pathways had been activated, there was very little
difference in the amounts of mRNA in both cell types (Figure
5D). Consistent with this ﬁnding, the kinetics of IL-6 secretion
by WT BECs and AC-3 KD BECs following exposure to E. coli
ORN103(pSH2) revealed a 3-h lag in the latter’s response, but
by 12 h the amounts of IL-6 secreted were comparable (Figure
6A). Thus, the rapid and vigorous inﬂammatory responses to
infection typically observed in the urinary tract may be
attributable, at least in part, to this distinct cAMP-dependent
signaling pathway. The relevance of the early IL-6 response by
BECs may be linked to their role as ﬁrst responders. One of
the primary cell types in the urinary tract reacting to BEC-
generated IL-6 are also BECs. These cells possess IL-6
receptors [54] and this cytokine, acting in autocrine fashion,
may trigger various antimicrobial responses, such as produc-
tion of antimicrobial peptides [55] and mucins, [56] as well as
promote exfoliation of infected BECs.
The existence of multiple pathways in BECs for triggering
IL-6 responses could be an adaptation to avoid inactivation
by UPEC. Several recent studies have suggested that host-
adapted pathogens possess the intrinsic capacity to block NF-
jB activation in macrophages and cultured human epithelial
cells through release of toxins or proteases [13,57–60].
Hunstad et al. have recently identiﬁed several genes (rfa, rfb,
and surA) in UPEC that contribute to suppressing the
cytokine responses of BECs [14]. Our observations that
primary BECs (Figure 7) evoked a more modest IL-6 response
to clinical UPEC CI5 compared to the laboratory E. coli strain
and that the cAMP/CREB–mediated IL-6 response to UPEC
CI5 in BEC lines was not striking compared to E. coli
ORN103(pSH2) (Figure 6A and 6B) could be manifestations
of this phenomenon. Conceivably, depending on the nature
of the BECs, the UPEC CI5 strain is able to partially diminish
one or both of the two TLR4-mediated signaling pathways
leading to IL-6 secretion.
Finally, because of the rapid emergence of multi-resistance
among UPEC isolates, there is mounting interest in the
development of alternate antimicrobial strategies. One
approach is to bolster innate immune defenses in the urinary
tract either before or during infection. In this regard, our
ﬁnding that small molecule enhancers of intracellular levels
of Ca
2þ and cAMP are sufﬁcient to trigger early and vigorous
cytokine responses from BECs is of interest. There are
available many compounds capable of modulating the intra-
cellular levels of both Ca
2þ and cAMP [31,61–63]. Judicious
application of some of these agents for the treatment and
prevention of urinary tract infections is a possibility that will
require further examination.
Supporting Information
Table S1. Gene-Speciﬁc Primers Used in This Study
Found at doi:10.1371/journal.ppat.0030060.st001 (16 KB PDF).
Text S1. KD Creation and Western Blot Analysis Methods
Found at doi:10.1371/journal.ppat.0030060.sd001 (62 KB PDF).
Acknowledgments
We thank Govind Gawdi for helpful comment and assistance in
calcium ﬂux analysis and Patrick Seed for critical reading of the
manuscript.
Author contributions. JS, MJD, and SNA conceived and designed
the experiments. JS and CC performed the experiments. JS, MJD, and
SNA analyzed the data. GL, RG, and AS contributed reagents/
materials/analysis tools. JS and SNA wrote the paper.
Funding. This work was supported in part with research grants
from the National Institutes of Health (AI 056101, AI 150021, and DK
050814).
Competing interests. The authors have declared that no competing
interests exist.
References
1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate
immunity. Cell 124: 783–801.
2. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816–825.
3. Schilling JD, Martin SM, Hunstad DA, Patel KP, Mulvey MA, et al. (2003)
CD14- and Toll-like receptor-dependent activation of bladder epithelial
cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun
71: 1470–1480.
4. Agace W, Hedges S, Andersson U, Andersson J, Ceska M, et al. (1993)
Selective cytokine production by epithelial cells following exposure to
Escherichia coli. Infect Immun 61: 602–609.
5. Haraoka M, Hang L, Frendeus B, Godaly G, Burdick M, et al. (1999)
Neutrophil recruitment and resistance to urinary tract infection. J Infect
Dis 180: 1220–1229.
6. Otto G, Braconier J, Andreasson A, Svanborg C (1999) Interleukin-6 and
disease severity in patients with bacteremic and nonbacteremic febrile
urinary tract infection. J Infect Dis 179: 172–179.
7. Gabay C (2006) Interleukin-6 and chronic inﬂammation. Arthritis Res Ther
8: S3.
8. Svanborg C, Godaly G (1997) Bacterial virulence in urinary tract infection.
Infect Dis Clin North Am 11: 513–529.
9. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ (2000) Type 1
pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19:
2801–2812.
10. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, et al. (1998)
Induction and evasion of host defenses by type 1-piliated uropathogenic
Escherichia coli. Science 282: 1494–1497.
11. Duncan MJ, Li G, Shin JS, Carson JL, Abraham SN (2004) Bacterial
penetration of bladder epithelium through lipid rafts. J Biol Chem 279:
18944–18951.
12. Roos V, Nielsen EM, Klemm P (2006) Asymptomatic bacteriuria Escherichia
coli strains: Adhesins, growth and competition. FEMS Microbiol Lett 262:
22–30.
13. Klumpp DJ, Weiser AC, Sengupta S, Forrestal SG, Batler RA, et al. (2001)
PLoS Pathogens | www.plospathogens.org April 2007 | Volume 3 | Issue 4 | e60 0551
A Novel TLR4 Pathway Leading to IL-6 in Human BECsUropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by
suppressing NF-kappaB. Infect Immun 69: 6689–6695.
14. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ (2005)
Suppression of bladder epithelial cytokine responses by uropathogenic
Escherichia coli. Infect Immun 73: 3999–4006.
15. Orndorff PE, Falkow S (1984) Identiﬁcation and characterization of a gene
product that regulates type 1 piliation in Escherichia coli. J Bacteriol 160: 61–
66.
16. Abraham SN, Babu JP, Giampapa CS, Hasty DL, Simpson WA, et al. (1985)
Protection against Escherichia coli-induced urinary tract infections with
hybridoma antibodies directed against type 1 ﬁmbriae or complementary
D-mannose receptors. Infect Immun 48: 625–628.
17. Thankavel K, Madison B, Ikeda T, Malaviya R, Shah AH, et al. (1997)
Localization of a domain in the FimH adhesin of Escherichia coli type 1
ﬁmbriae capable of receptor recognition and use of a domain-speciﬁc
antibody to confer protection against experimental urinary tract infection.
J Clin Invest 100: 1123–1136.
18. Cross WR, Eardley I, Leese HJ, Southgate J (2005) A biomimetic tissue from
cultured normal human urothelial cells: Analysis of physiological function.
Am J Physiol Renal Physiol 289: F459–F468.
19. Wright EL, Quenelle DC, Suling WJ, Barrow WW (1996) Use of Mono Mac 6
human monocytic cell line and J774 murine macrophage cell line in
parallel antimycobacterial drug studies. Antimicrob Agents Chemother 40:
2206–2208.
20. Uhlen P, Laestadius A, Jahnukainen T, Soderblom T, Backhed F, et al.
(2000) Alpha-haemolysin of uropathogenic E. coli induces Ca2þoscillations
in renal epithelial cells. Nature 405: 694–697.
21. Ludwig MG, Seuwen K (2002) Characterization of the human adenylyl
cyclase gene family: cDNA, gene structure, and tissue distribution of the
nine isoforms. J Recept Signal Transduct Res 22: 79–110.
22. Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, et al. (2006) The cytokine
interleukin-6 is sufﬁcient but not necessary to mimic the peripheral
conditioning lesion effect on axonal growth. J Neurosci 26: 5565–5573.
23. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ (2001)
Bacterial invasion augments epithelial cytokine responses to Escherichia coli
through a lipopolysaccharide-dependent mechanism. J Immunol 166:
1148–1155.
24. Song PI, Abraham TA, Park Y, Zivony AS, Harten B, et al. (2001) The
expression of functional LPS receptor proteins CD14 and toll-like receptor
4 in human corneal cells. Invest Ophthalmol Vis Sci 42: 2867–2877.
25. Belmeguenai A, Desrues L, Leprince J, Vaudry H, Tonon MC, et al. (2003)
Neurotensin stimulates both calcium mobilization from inositol tri-
sphosphate-sensitive intracellular stores and calcium inﬂux through
membrane channels in frog pituitary melanotrophs. Endocrinology 144:
5556–5567.
26. Bissonnette M, Tien XY, Niedziela SM, Hartmann SC, Frawley BPJ, et al.
(1994) 1,25(OH)2 vitamin D3 activates PKC-alpha in Caco-2 cells: A
mechanism to limit secosteroid-induced rise in [Ca2þ]i. Am J Physiol 267:
G465–G475.
27. Zhang Y, Mahendran R, Yap LL, Esuvaranathan K, Khoo HE (2002) The
signalling pathway for BCG-induced interleukin-6 production in human
bladder cancer cells. Biochem Pharmacol 63: 273–282.
28. Yadav M, Roach SK, Schorey JS (2004) Increased mitogen-activated protein
kinase activity and TNF-alpha production associated with Mycobacterium
smegmatis- but not Mycobacterium avium-infected macrophages requires
prolonged stimulation of the calmodulin/calmodulin kinase and cyclic
AMP/protein kinase A pathways. J Immunol 172: 5588–5597.
29. Chio CC, Chang YH, Hsu YW, Chi KH, Lin WW (2004) PKA-dependent
activation of PKC, p38 MAPK and IKK in macrophage: Implication in the
induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl
cAMP. Cell Signal 16: 565–575.
30. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, et al.
(2002) A novel Epac-speciﬁc cAMP analogue demonstrates independent
regulation of Rap1 and ERK. Nat Cell Biol 4: 901–906.
31. Insel PA, Ostrom RS (2003) Forskolin as a tool for examining adenylyl
cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol
23: 305–314.
32. Sunahara RK, Taussig R (2002) Isoforms of mammalian adenylyl cyclase:
Multiplicities of signaling. Mol Interv 2: 168–184.
33. Cooper DM, Mons N, Fagan K (1994) Ca(2þ)-sensitive adenylyl cyclases. Cell
Signal 6: 823–840.
34. Choi EJ, Xia Z, Storm DR (1992) Stimulation of the type III olfactory
adenylyl cyclase by calcium and calmodulin. Biochemistry 31: 6492–6498.
35. Dendorfer U (1996) Molecular biology of cytokines. Artif Organs 20: 437–
444.
36. Shaywitz AJ, Greenberg ME (1999) CREB: A stimulus-induced transcription
factor activated by a diverse array of extracellular signals. Annu Rev
Biochem 68: 821–861.
37. Andrisani OM (1999) CREB-mediated transcriptional control. Crit Rev
Eukaryot Gene Expr 9: 19–32.
38. Mori N, Shirakawa F, Shimizu H, Murakami S, Oda S, et al. (1994)
Transcriptional regulation of the human interleukin-6 gene promoter in
human T-cell leukemia virus type I-infected T-cell lines: Evidence for the
involvement of NF-kappa B. Blood 84: 2904–2911.
39. Franz M, Horl WH (1999) Common errors in diagnosis and management of
urinary tract infection. I: Pathophysiology and diagnostic techniques.
Nephrol Dial Transplant 14: 2746–2753.
40. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C (2004) Toll-like
receptor 4 expression and cytokine responses in the human urinary tract
mucosa. Infect Immun 72: 3179–3186.
41. Liu SF, Ye X, Malik AB (1999) Pyrrolidine dithiocarbamate prevents I-
kappaB degradation and reduces microvascular injury induced by lip-
opolysaccharide in multiple organs. Mol Pharmacol 55: 658–667.
42. Liu SF, Ye X, Malik AB (1999) Inhibition of NF-kappaB activation by
pyrrolidine dithiocarbamate prevents In vivo expression of proinﬂamma-
tory genes. Circulation 100: 1330–1337.
43. Backhed F, Soderhall M, Ekman P, Normark S, Richter-Dahlfors A (2001)
Induction of innate immune responses by Escherichia coli and puriﬁed
lipopolysaccharide correlate with organ- and cell-speciﬁc expression of
Toll-like receptors within the human urinary tract. Cell Microbiol 3: 153–
158.
44. Cilento BG, Freeman MR, Schneck FX, Retik AB, Atala A (1994) Phenotypic
and cytogenetic characterization of human bladder urothelia expanded in
vitro. J Urol 152: 665–670.
45. Hedlund M, Duan RD, Nilsson A, Svensson M, Karpman D, et al. (2001)
Fimbriae, transmembrane signaling, and cell activation. J Infect Dis 183:
S47–S50.
46. Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, et al. (2006)
Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr
Opin Microbiol 9: 33–39.
47. Pulendran B, Palucka K, Banchereau J (2001) Sensing pathogens and tuning
immune responses. Science 293: 253–256.
48. Seabra V, Stachlewitz RF, Thurman RG (1998) Taurine blunts LPS-induced
increases in intracellular calcium and TNF-alpha production by Kupffer
cells. J Leukoc Biol 64: 615–621.
49. Oshiro A, Otani H, Yagi Y, Fukuhara S, Inagaki C (2004) Protease-activated
receptor-2-mediated inhibition for Ca2þresponse to lipopolysaccharide in
Guinea pig tracheal epithelial cells. Am J Respir Cell Mol Biol 30: 886–892.
50. Rodeberg DA, Babcock GF (1996) Role of calcium during lipopolysacchar-
ide stimulation of neutrophils. Infect Immun 64: 2812–2816.
51. Gray JG, Chandra G, Clay WC, Stinnett SW, Haneline SA, et al. (1993) A
CRE/ATF-like site in the upstream regulatory sequence of the human
interleukin 1 beta gene is necessary for induction in U937 and THP-1
monocytic cell lines. Mol Cell Biol 13: 6678–6689.
52. Isshiki H, Akira S, Tanabe O, Nakajima T, Shimamoto T, et al. (1990)
Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-
1-responsive element in the IL-6 gene. Mol Cell Biol 10: 2757–2764.
53. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, et al. (2003)
Identiﬁcation of a family of cAMP response element-binding protein
coactivators by genome-scale functional analysis in mammalian cells. Proc
Natl Acad Sci U S A 100: 12147–12152.
54. Meyers FJ, Gumerlock PH, Kawasaki ES, Wang AM, deVere White RW, et al.
(1991) Bladder cancer. Human leukocyte antigen II, interleukin-6, and
interleukin-6 receptor expression determined by the polymerase chain
reaction. Cancer 67: 2087–2095.
55. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, et al. (2004) IL-6
mediates hypoferremia of inﬂammation by inducing the synthesis of the
iron regulatory hormone hepcidin. J Clin Invest 113: 1271–1276.
56. Li X, Wang L, Nunes DP, Troxler RF, Offner GD (2003) Pro-inﬂammatory
cytokines up-regulate MUC1 gene expression in oral epithelial cells. J Dent
Res 82: 883–887.
57. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, et al. (2002)
Cutting edge: Salmonella AvrA effector inhibits the key proinﬂammatory,
anti-apoptotic NF-kappa B pathway. J Immunol 169: 2846–2850.
58. Tato CM, Hunter CA (2002) Host-pathogen interactions: Subversion and
utilization of the NF-kappa B pathway during infection. Infect Immun 70:
3311–3317.
59. Ruckdeschel K, Mannel O, Richter K, Jacobi CA, Trulzsch K, et al. (2001)
Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the
nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling
to trigger apoptosis in macrophages. J Immunol 166: 1823–1831.
60. Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, et al. (2000) Disruption of
signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
Science 290: 1594–1597.
61. Shafer SH, Phelps SH, Williams CL (1998) Reduced DNA synthesis and cell
viability in small cell lung carcinoma by treatment with cyclic AMP
phosphodiesterase inhibitors. Biochem Pharmacol 56: 1229–1236.
62. Pressman BC (1976) Biological applications of ionophores. Annu Rev
Biochem 45: 501–530.
63. Elmslie KS (2004) Calcium channel blockers in the treatment of disease. J
Neurosci Res 75: 733–741.
PLoS Pathogens | www.plospathogens.org April 2007 | Volume 3 | Issue 4 | e60 0552
A Novel TLR4 Pathway Leading to IL-6 in Human BECs